LUMIQUICK DIAGNOSTICS, INC.

Home/Brands/LUMIQUICK DIAGNOSTICS, INC.

LUMIQUICK DIAGNOSTICS, INC.

Main Filters

LUMIQUICK DIAGNOSTICS, INC.

LUMIQUICK DIAGNOSTICS, INC.
CATALOG #	QTY	PRICE	DESCRIPTION
07RD7001	0	-	immunochromatographic test (IVD) for Human chorionic gonadotropin beta-subunit (beta-HCG)
07RD7005	0	-	Immunoassay for the detection of methamphetamine in human urine
07RD7006	0	-	Immunoassay for the detection of methamphetamine in human urine
07RD7007	0	-	Immunoassay for the detection of cocaine in human urine
07RD7008	0	-	Immunoassay for the detection of cocaine in human urine
07RD7009	0	-	Immunoassay for the detection of THC in human urine
07RD7010	0	-	Immunoassay for the detection of THC in human urine
07RD7011	0	-	Immunoassay for the detection of opiate in human urine
07RD7012	0	-	Immunoassay for the detection of opiate in human urine
07RD7013	0	-	Immunoassay for the detection of amphetamine in human urine
07RD7014	0	-	Immunoassay for the detection of amphetamine in human urine
07RD7015	0	-	Immunoassay for the detection of barbiturate in human urine
07RD7016	0	-	Immunoassay for the detection of barbiturate in human urine
07RD7017	0	-	Immunoassay for the detection of benzodiazepine in human urine
07RD7018	0	-	Immunoassay for the detection of benzodiazepine in human urine
07RD7019	0	-	Immunoassay for the detection of methadone in human urine
07RD7020	0	-	Immunoassay for the detection of methadone in human urine
07RD7021	0	-	Immunoassay for the detection of PCP in human urine
07RD7022	0	-	Immunoassay for the detection of PCP in human urine
07RD7061-01	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: COC / THC
07RD7061-02A	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: M-AMP / OPI-2000
07RD7061-03	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: MAMP / THC
07RD7061-04A	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: BZD / OPI-2000
07RD7062-02	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: COC / M-AMP / THC
07RD7062-04	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: COC / OPI / THC
07RD7063-01	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: AMP / COC / OPI / THC
07RD7063-02	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: COC / M-AMP / OPI / THC
07RD7063-03	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: BZD / COC / MTD / OPI
07RD7063-28	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: BUP / MTD / OPI / OXY
07RD7064-01	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: AMP / COC / OPI / PCP / THC
07RD7064-02	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: COC / M-AMP / OPI / PCP / THC
07RD7064-03	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: AMP / COC / M-AMP / OPI / THC
07RD7065-22	0	-	Immunoassay for the detection of the following drug substance(s) in human urine: BUP / BZD / COC / OPI / OXY / THC
1N40C5-1-US-BS	0	-	The Rapid SARS-CoV-2 Antigen Test Card is a single use rapid lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 and older, when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.This test is also authorized for non-prescription home use with adult-collected anterior nasal (nares) swab samples from individuals aged 2 years and older when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals aged 2 years and older with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.

134 Results

Results Per Page

Catalog #

Available

Starting At

Name

Company Name

Description

07RD7064-03

QuickProfile™ Drugs of Abuse Panel 5 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: AMP / COC / M-AMP / OPI / THC

07RD7064-02

QuickProfile™ Drugs of Abuse Panel 5 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: COC / M-AMP / OPI / PCP / THC

07RD7064-01

QuickProfile™ Drugs of Abuse Panel 5 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: AMP / COC / OPI / PCP / THC

07RD7063-28

QuickProfile™ Drugs of Abuse Panel 4 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: BUP / MTD / OPI / OXY

07RD7063-03

QuickProfile™ Drugs of Abuse Panel 4 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: BZD / COC / MTD / OPI

07RD7063-02

QuickProfile™ Drugs of Abuse Panel 4 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: COC / M-AMP / OPI / THC

07RD7063-01

QuickProfile™ Drugs of Abuse Panel 4 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: AMP / COC / OPI / THC

07RD7062-04

QuickProfile™ Drugs of Abuse Panel 3 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: COC / OPI / THC

07RD7062-02

QuickProfile™ Drugs of Abuse Panel 3 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: COC / M-AMP / THC

07RD7061-04A

QuickProfile™ Drugs of Abuse Panel 2 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: BZD / OPI-2000

07RD7061-03

QuickProfile™ Drugs of Abuse Panel 2 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: MAMP / THC

07RD7061-02A

QuickProfile™ Drugs of Abuse Panel 2 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: M-AMP / OPI-2000

07RD7061-01

QuickProfile™ Drugs of Abuse Panel 2 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: COC / THC

07RD7022

QuickProfile™ PCP Test Card

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of PCP in human urine

07RD7021

QuickProfile™ PCP Test Strip

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of PCP in human urine

07RD7020

QuickProfile™ Methadone Test Card

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of methadone in human urine

07RD7019

QuickProfile™ Methadone Test Strip

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of methadone in human urine

07RD7018

QuickProfile™ Benzodiazepine Test Card

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of benzodiazepine in human urine

07RD7017

QuickProfile™ Benzodiazepine Test Strip

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of benzodiazepine in human urine

07RD7016

QuickProfile™ Barbiturate Test Card

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of barbiturate in human urine

07RD7015

QuickProfile™ Barbiturate Test Strip

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of barbiturate in human urine

07RD7014

QuickProfile™ Amphetamine Test Card

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of amphetamine in human urine

07RD7013

QuickProfile™ Amphetamine Test Strip

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of amphetamine in human urine

07RD7012

QuickProfile™ Opiate Test Card

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of opiate in human urine

07RD7011

QuickProfile™ Opiate Test Strip

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of opiate in human urine

07RD7010

QuickProfile™ THC Test Card

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of THC in human urine

07RD7009

QuickProfile™ THC Test Strip

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of THC in human urine

07RD7008

QuickProfile™ Cocaine Test Card

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of cocaine in human urine

07RD7007

QuickProfile™ Cocaine Test Strip

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of cocaine in human urine

07RD7006

QuickProfile™ Methamphetamine Test Card

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of methamphetamine in human urine

07RD7005

QuickProfile™ Methamphetamine Test Strip

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of methamphetamine in human urine

07RD7001

QuickProfile™ HCG Test Strip

LUMIQUICK DIAGNOSTICS, INC.

immunochromatographic test (IVD) for Human chorionic gonadotropin beta-subunit (beta-HCG)

07RD7065-22

QuickProfile™ Drugs of Abuse Panel 6 Test

LUMIQUICK DIAGNOSTICS, INC.

Immunoassay for the detection of the following drug substance(s) in human urine: BUP / BZD / COC / OPI / OXY / THC

1N40C5-1-US-BS

Rapid SARS-CoV-2 Antigen Test Card

LUMIQUICK DIAGNOSTICS, INC.

The Rapid SARS-CoV-2 Antigen Test Card is a single use rapid lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 and older, when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.This test is also authorized for non-prescription home use with adult-collected anterior nasal (nares) swab samples from individuals aged 2 years and older when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals aged 2 years and older with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.